Conversely, immunoparesis with involvement of both Ig classes, and prior anti-MM therapies including PIs (proteasome inhibitors) or anti-CD38 monoclonal antibodies (MoAbs), were associated with an impaired humoral response at all time-points (Table 3). The gene discussed is CD38; the disease is Miyoshi myopathy.